Skip to main content
. 2014 Mar 20;8(3):e2727. doi: 10.1371/journal.pntd.0002727

Figure 5. Prototype AMD LFI for detection of B. pseudomallei CPS in melioidosis patient samples.

Figure 5

(A) Preliminary testing of a variety of archived patient samples from Australia and Thailand. (B) Detection of CPS in melioidosis patient urine samples (filtered) listed in Table 2. Urine (50 µl) was combined with 100 µl of chase buffer and applied to the sample pad. Note that samples that were positive by antigen-capture immunoassay (Table 2) were also positive by LFI and the levels of CPS detected between both assays are congruent.